Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Oxytocin and Dopamine Stimulate Ghrelin Secretion by the Ghrelin-Producing Cell Line, MGN3-1 in Vitro

View through CrossRef
To understand the physiological role of ghrelin, it is crucial to study both the actions of ghrelin and the regulation of ghrelin secretion. Although ghrelin actions have been extensively revealed, the direct factors regulating ghrelin secretion by ghrelin-producing cells (X/A-like cells), however, is not fully understood. In this study, we examined the effects of peptide hormones and neurotransmitters on in vitro ghrelin secretion by the recently developed ghrelin-producing cell line MGN3-1. Oxytocin and vasopressin significantly stimulated ghrelin secretion by MGN3-1 cells. Because MGN3-1 cells express only oxytocin receptor mRNA, not vasopressin receptor mRNA, oxytocin is the likely regulator, with the effect of vasopressin mediated by a cross-reaction. We also discovered that dopamine stimulates ghrelin secretion from MGN3-1 cells in a similar manner to the previously known ghrelin stimulators, epinephrine and norepinephrine. MGN3-1 cells expressed mRNA encoding dopamine receptors D1a and D2. The dopamine receptor D1 agonist fenoldopam stimulated ghrelin secretion, whereas the D2, D3 agonist bromocriptine did not. Furthermore, the D1 receptor antagonist SKF83566 attenuated the stimulatory effect of dopamine. These results indicate that the stimulatory effect of dopamine on ghrelin secretion is mediated by the D1a receptor. In conclusion, we identified two direct regulators of ghrelin, oxytocin and dopamine. These findings will provide new direction for further studies seeking to further understand the regulation of ghrelin secretion, which will in turn lead to greater understanding of the physiological role of ghrelin.
Title: Oxytocin and Dopamine Stimulate Ghrelin Secretion by the Ghrelin-Producing Cell Line, MGN3-1 in Vitro
Description:
To understand the physiological role of ghrelin, it is crucial to study both the actions of ghrelin and the regulation of ghrelin secretion.
Although ghrelin actions have been extensively revealed, the direct factors regulating ghrelin secretion by ghrelin-producing cells (X/A-like cells), however, is not fully understood.
In this study, we examined the effects of peptide hormones and neurotransmitters on in vitro ghrelin secretion by the recently developed ghrelin-producing cell line MGN3-1.
Oxytocin and vasopressin significantly stimulated ghrelin secretion by MGN3-1 cells.
Because MGN3-1 cells express only oxytocin receptor mRNA, not vasopressin receptor mRNA, oxytocin is the likely regulator, with the effect of vasopressin mediated by a cross-reaction.
We also discovered that dopamine stimulates ghrelin secretion from MGN3-1 cells in a similar manner to the previously known ghrelin stimulators, epinephrine and norepinephrine.
MGN3-1 cells expressed mRNA encoding dopamine receptors D1a and D2.
The dopamine receptor D1 agonist fenoldopam stimulated ghrelin secretion, whereas the D2, D3 agonist bromocriptine did not.
Furthermore, the D1 receptor antagonist SKF83566 attenuated the stimulatory effect of dopamine.
These results indicate that the stimulatory effect of dopamine on ghrelin secretion is mediated by the D1a receptor.
In conclusion, we identified two direct regulators of ghrelin, oxytocin and dopamine.
These findings will provide new direction for further studies seeking to further understand the regulation of ghrelin secretion, which will in turn lead to greater understanding of the physiological role of ghrelin.

Related Results

Establishment of a Novel Ghrelin-Producing Cell Line
Establishment of a Novel Ghrelin-Producing Cell Line
To establish a tool to study ghrelin production and secretion in vitro, we developed a novel ghrelin-producing cell line, MGN3–1 (mouse ghrelinoma 3-1) cells from a gastric ghrelin...
Comprehensive Profiling of GPCR Expression in Ghrelin-Producing Cells
Comprehensive Profiling of GPCR Expression in Ghrelin-Producing Cells
Abstract To determine the comprehensive G protein-coupled receptor (GPCR) expression profile in ghrelin-producing cells and to elucidate the role of GPCR-mediated si...
Potential Role of TRPV4 in Stretch-Induced Ghrelin Secretion and Obesity
Potential Role of TRPV4 in Stretch-Induced Ghrelin Secretion and Obesity
Obesity is an important health problem, which can be prevented through appetite control. Ghrelin is an appetite-stimulating hormone considered to promote obesity. Thus, we examined...
Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy
Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy
OBJECTIVE: Ghrelin stimulates growth hormone (GH) secretion both in vivo and in vitro. Ghrelin is mainly produced in and released from the stomach but it is probably also produced ...
Exploring the in vivo subthreshold membrane activity of phasic firing in midbrain dopamine neurons
Exploring the in vivo subthreshold membrane activity of phasic firing in midbrain dopamine neurons
Dopamine is a key neurotransmitter that serves several essential functions in daily behaviors such as locomotion, motivation, stimulus coding, and learning. Disrupted dopamine circ...
Suppression of Insulin Secretion by Ghrelin and The Deterioration of Glucose Tolerance in Healthy Children
Suppression of Insulin Secretion by Ghrelin and The Deterioration of Glucose Tolerance in Healthy Children
Background: Ghrelin, identified as an endogenous ligand for the growth hormone secretagogue receptor, functions as a somatotrophic and orexigenic signal from the stomach. The secre...
Aqueous humour ghrelin levels of eyes with and without glaucoma
Aqueous humour ghrelin levels of eyes with and without glaucoma
Abstract Purpose Ghrelin is a recently described acylated peptide, which works as a somatosecretagogue and modulates smooth, skeletal and cardiac muscles contraction, including tha...
Abstract 1856: Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
Abstract 1856: Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
Abstract ONC201 (originally discovered as TRAIL-Inducing Compound #10 or TIC10) and analogue ONC206 have been found to induce an integrated stress response with sugg...

Back to Top